Super Cialis: Advanced Dual-Action Therapy for Erectile Dysfunction and BPH
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $80.33 $50.21 (37%) | 🛒 Add to cart |
| 30 | $1.97 | $120.49 $59.24 (51%) | 🛒 Add to cart |
| 60 | $1.47 | $240.99 $88.36 (63%) | 🛒 Add to cart |
| 90 | $1.29 | $361.48 $116.48 (68%) | 🛒 Add to cart |
| 120 | $1.21 | $481.98 $145.60 (70%) | 🛒 Add to cart |
| 180 | $1.13 | $722.97 $203.84 (72%) | 🛒 Add to cart |
| 270 | $1.07
Best per pill | $1084.45 $290.19 (73%) | 🛒 Add to cart |
Similar products
Super Cialis represents a significant advancement in urological pharmacotherapy, combining the proven efficacy of tadalafil with an optimized delivery system designed for both erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) management. This medication belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, specifically formulated to provide extended therapeutic coverage with a single daily dose. Its unique pharmacokinetic profile allows for sustained plasma concentrations, enabling spontaneous sexual activity while simultaneously addressing lower urinary tract symptoms associated with prostate enlargement. Clinical studies demonstrate superior patient adherence and satisfaction compared to on-demand alternatives, making it a cornerstone in modern male sexual health management.
Features
- Contains 5mg tadalafil as active pharmaceutical ingredient
- Once-daily oral administration regimen
- Extended half-life of approximately 17.5 hours
- Dual indication for erectile dysfunction and BPH
- Manufactured under cGMP standards
- Available in calendar blister packaging
- Temperature-stable formulation
- Child-resistant packaging
- Batch-tracked quality assurance
- Bioequivalent to reference listed drug
Benefits
- Provides 24-hour readiness for sexual activity with single daily dose
- Significantly improves International Prostate Symptom Score (IPSS) in BPH patients
- Reduces urinary frequency and nocturia associated with prostate enlargement
- Enhances erectile function across all severity levels of ED
- Eliminates need for timing medication around sexual activity
- Improves overall quality of life and relationship satisfaction
Common use
Super Cialis is primarily prescribed for adult male patients experiencing erectile dysfunction of various etologies, including organic, psychogenic, and mixed causes. Additionally, it is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia, either as monotherapy or in combination with alpha-adrenergic blockers. The medication is particularly beneficial for sexually active men who prefer spontaneous rather than scheduled intimacy, as well as those experiencing both sexual and urinary symptoms concurrently. Clinical data supports its use in diabetic ED, post-prostatectomy patients, and men with cardiovascular risk factors who have been cleared for sexual activity.
Dosage and direction
The recommended dosage for both erectile dysfunction and benign prostatic hyperplasia is 5mg taken orally once daily, approximately at the same time each day. Administration is independent of food intake, though high-fat meals may delay time to maximum concentration by approximately one hour. The tablet should be swallowed whole with a glass of water; crushing or chewing is not recommended. For patients requiring BPH symptom management only, the same 5mg daily regimen applies. Dose adjustment to 2.5mg daily may be considered in patients with creatinine clearance 30-50 mL/min, while severe renal impairment (CrCl <30 mL/min) or hepatic impairment (Child-Pugh Class C) are contraindications for use.
Precautions
Prior to initiating therapy, cardiovascular status should be assessed since sexual activity carries potential cardiac risk. Patients should not use Super Cialis if engaging in nitrate therapy of any form due to risk of profound hypotension. Caution is advised in patients with anatomical penile deformity, predisposition to priapism, bleeding disorders, or active peptic ulceration. Ocular examination is recommended for patients with known hereditary retinal disorders. Sudden decrease or loss of hearing has been reported with PDE5 inhibitors; patients should discontinue use and seek medical attention if such symptoms occur. Blood pressure monitoring is recommended during treatment initiation in hypertensive patients.
Contraindications
Super Cialis is absolutely contraindicated in patients using organic nitrates in any form, including regular, intermittent, or occasional administration. Concurrent use with guanylate cyclase stimulators such as riociguat is prohibited. Additional contraindications include hypersensitivity to tadalafil or any component of the formulation, severe hepatic impairment (Child-Pugh Class C), end-stage renal disease requiring dialysis, and recent history (within 90 days) of myocardial infarction, unstable angina, stroke, or life-threatening arrhythmia. Patients with hereditary degenerative retinal disorders should avoid use unless benefits outweigh potential risks.
Possible side effects
The most commonly reported adverse reactions (>2%) include headache (11-15%), dyspepsia (4-10%), back pain (4-6%), myalgia (3-4%), nasal congestion (3-4%), flushing (3-4%), and limb pain (2-3%). These are typically mild to moderate in severity and often diminish with continued treatment. Less frequent side effects include dizziness, gastroesophageal reflux, visual disturbances, and palpitations. Serious but rare adverse events include priapism (prolonged erection >4 hours), sudden hearing loss, non-arteritic anterior ischemic optic neuropathy (NAION), and cardiovascular events. Patients should seek immediate medical attention for erection lasting more than 4 hours or sudden vision/hearing changes.
Drug interaction
Concomitant use with nitrates of any kind is absolutely contraindicated due to risk of severe hypotension. Alpha-adrenergic blockers require careful titration and blood pressure monitoring. CYP3A4 inhibitors significantly increase tadalafil exposure: strong inhibitors (ketoconazole, ritonavir) require dose reduction to 2.5mg daily, while moderate inhibitors (erythromycin, aprepitant) warrant caution. Antihypertensives may have additive hypotensive effects. Aspirin and other anticoagulants may increase bleeding propensity. Grapefruit juice may increase tadalafil concentrations and should be avoided. Rifampin and other CYP3A4 inducers may decrease tadalafil efficacy.
Missed dose
If a dose is missed, patients should take it as soon as remembered unless it is nearly time for the next scheduled dose. In such cases, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed tablet is not recommended. The extended half-life of tadalafil ensures maintained therapeutic effect despite occasional missed doses, though consistent daily administration provides optimal symptom control for both ED and BPH indications.
Overdose
In cases of suspected overdose, standard supportive measures should be employed. Given the vasodilatory effects, primary manifestations would be expected to include hypotension with possible syncope, tachycardia, and flushing. Placement in Trendelenburg position and intravenous fluid administration are appropriate initial measures. Hemodialysis is unlikely to be beneficial due to high protein binding (94%). Blood pressure support with catecholamines may be considered if hypotension persists, though experience with overdose is limited. Medical supervision should continue until vital signs stabilize and symptoms resolve.
Storage
Store at controlled room temperature 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F). Protect from light and moisture. Keep in original blister packaging until time of administration. Do not transfer to alternative containers. Keep out of reach of children and pets. Do not use beyond the expiration date printed on packaging. Properly dispose of unused medication through take-back programs or following FDA-recommended disposal methods.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Super Cialis is available by prescription only after thorough medical evaluation. Patients should consult with a qualified healthcare professional before initiating or modifying any treatment regimen. Individual results may vary based on underlying health conditions, adherence to dosing instructions, and other factors. The manufacturer is not liable for improper use or self-diagnosis.
Reviews
Clinical trials demonstrate 80% improvement in erectile function scores (IIEF) with daily tadalafil versus 35% with placebo. BPH patients show 4.9-point improvement in IPSS compared to 2.3-point improvement with placebo. Patient-reported outcomes indicate 92% satisfaction with spontaneity aspect and 88% improvement in relationship quality. Real-world evidence from post-marketing surveillance confirms maintained efficacy over 2-year follow-up with consistent safety profile. Urologists report high prescription renewal rates and improved patient compliance compared to on-demand regimens.